Genetically Engineered Microorganisms and Their Impact on Human Health

被引:9
作者
Ari, Marzie Mahdizade [1 ,2 ]
Dadgar, Leila [1 ,2 ]
Elahi, Zahra [1 ,2 ]
Ghanavati, Roya [3 ]
Taheri, Behrouz [4 ]
机构
[1] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran
[2] Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran
[3] Behbahan Fac Med Sci, Behbahan, Iran
[4] Ahvaz Jundishapour Univ Med Sci, Sch Med, Dept Orthopaed, Ahvaz, Iran
关键词
COLI NISSLE 1917; INFLAMMATORY-BOWEL-DISEASE; LACTIC-ACID BACTERIA; PHASE-I TRIAL; LACTOCOCCUS-LACTIS; BIFIDOBACTERIUM-LONGUM; COMMENSAL BACTERIUM; SALMONELLA-TYPHIMURIUM; BIOLOGICAL CONTAINMENT; ASPERGILLUS-NIDULANS;
D O I
10.1155/2024/6638269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The emergence of antibiotic-resistant strains, the decreased effectiveness of conventional therapies, and the side effects have led researchers to seek a safer, more cost-effective, patient-friendly, and effective method that does not develop antibiotic resistance. With progress in synthetic biology and genetic engineering, genetically engineered microorganisms effective in treatment, prophylaxis, drug delivery, and diagnosis have been developed. The present study reviews the types of genetically engineered bacteria and phages, their impacts on diseases, cancer, and metabolic and inflammatory disorders, the biosynthesis of these modified strains, the route of administration, and their effects on the environment. We conclude that genetically engineered microorganisms can be considered promising candidates for adjunctive treatment of diseases and cancers.
引用
收藏
页数:38
相关论文
共 289 条
  • [1] Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth
    Abedon, Stephen T.
    Danis-Wlodarczyk, Katarzyna M.
    Wozniak, Daniel J.
    [J]. PHARMACEUTICALS, 2021, 14 (10)
  • [2] Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering
    Adolfsen, Kristin J.
    Callihan, Isolde
    Monahan, Catherine E.
    Greisen, Per
    Spoonamore, James
    Momin, Munira
    Fitch, Lauren E.
    Castillo, Mary Joan
    Weng, Lindong
    Renaud, Lauren
    Weile, Carl J.
    Konieczka, Jay H.
    Mirabella, Teodelinda
    Abin-Fuentes, Andres
    Lawrence, Adam G.
    Isabella, Vincent M.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [3] Engineering probiotics for therapeutic applications: recent examples and translational outlook
    Aggarwal, Nikhil
    Breedon, Amy M. Ehrenworth
    Davis, Christina M.
    Hwang, In Young
    Chang, Matthew Wook
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2020, 65 : 171 - 179
  • [4] Bacteria-mediated delivery of nanoparticles and cargo into cells
    Akin, Demir
    Sturgis, Jennifer
    Ragheb, Kathy
    Sherman, Debby
    Burkholder, Kristin
    Robinson, J. Paul
    Bhunia, Arun K.
    Mohammed, Sulma
    Bashir, Rashid
    [J]. NATURE NANOTECHNOLOGY, 2007, 2 (07) : 441 - 449
  • [5] Sustainable therapies by engineered bacteria
    Alvarez, Beatriz
    Angel Fernandez, Luis
    [J]. MICROBIAL BIOTECHNOLOGY, 2017, 10 (05): : 1057 - 1061
  • [6] Tailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers
    Anand, Prachi
    O'Neil, Alison
    Lin, Emily
    Douglas, Trevor
    Holford, Mande
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [7] [Anonymous], 2010, CNIoGECoFSitUWDNAP
  • [8] The potential use of theranostic bacteria in cancer
    Azizian, Khalil
    Pustokhina, Inna
    Ghanavati, Roya
    Hamblin, Michael R.
    Amini, Abolfazl
    Kouhsari, Ebrahim
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (06) : 4184 - 4194
  • [9] Targeted drug delivery to tumors: Myths, reality and possibility
    Bae, You Han
    Park, Kinam
    [J]. JOURNAL OF CONTROLLED RELEASE, 2011, 153 (03) : 198 - 205
  • [10] Killing cancer cells by targeted drug-carrying phage nanomedicines
    Bar, Hagit
    Yacoby, Iftach
    Benhar, Itai
    [J]. BMC BIOTECHNOLOGY, 2008, 8 (1)